{"id":"https://openalex.org/W2397627572","doi":"https://doi.org/10.1158/1535-7163.targ-15-c11","title":"Abstract C11: Protein biomarkers predictive of outcome in EGFR inhibitor-treated non-small cell lung cancer patients with EGFR wildtype","display_name":"Abstract C11: Protein biomarkers predictive of outcome in EGFR inhibitor-treated non-small cell lung cancer patients with EGFR wildtype","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2397627572","doi":"https://doi.org/10.1158/1535-7163.targ-15-c11","mag":"2397627572"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-15-c11","doi":"https://doi.org/10.1158/1535-7163.targ-15-c11","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c11","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103994141","display_name":"Kirstine Jacobsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kirstine Jacobsen","raw_affiliation_strings":["1University of Southern Denmark, Odense C, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Southern Denmark, Odense C, Denmark;","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060699409","display_name":"Brian L. Hood","orcid":"https://orcid.org/0000-0002-2398-487X","observed_orcids":["https://orcid.org/0000-0002-2398-487X"]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Hood","raw_affiliation_strings":["2Women's Health Integrated Research Center at Inova Health System, Annandale, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Women's Health Integrated Research Center at Inova Health System, Annandale, VA;","institution_ids":["https://openalex.org/I116530498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109975712","display_name":"Karen Ege Olsen","orcid":"https://orcid.org/0000-0002-6517-1172","observed_orcids":["https://orcid.org/0000-0002-6517-1172"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Ege Olsen","raw_affiliation_strings":["3Department of Clinical Pathology, Odense C, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Clinical Pathology, Odense C, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080595928","display_name":"Thomas P. Conrads","orcid":"https://orcid.org/0000-0003-4742-3281","observed_orcids":["https://orcid.org/0000-0003-4742-3281"]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Conrads","raw_affiliation_strings":["2Women's Health Integrated Research Center at Inova Health System, Annandale, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Women's Health Integrated Research Center at Inova Health System, Annandale, VA;","institution_ids":["https://openalex.org/I116530498"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011720560","display_name":"Henrik J. Ditzel","orcid":"https://orcid.org/0000-0003-3927-5135","observed_orcids":["https://orcid.org/0000-0003-3927-5135"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Henrik Ditzel","raw_affiliation_strings":["1University of Southern Denmark, Odense C, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Southern Denmark, Odense C, Denmark;","institution_ids":["https://openalex.org/I177969490"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"12_Supplement_2","first_page":"C11","last_page":"C11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9869999885559082},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":1.0},{"id":"https://openalex.org/keywords/protein-biomarkers","display_name":"protein biomarkers","score":0.8080000281333923},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7059999704360962},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/differentially-expressed-proteins","display_name":"differentially expressed proteins","score":0.7739999890327454},{"id":"https://openalex.org/keywords/cancer-proteome","display_name":"tumor proteome","score":0.41100001335144043},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.6830000281333923},{"id":"https://openalex.org/keywords/bronchioloalveolar-carcinoma","display_name":"bronchioloalveolar carcinoma","score":0.7059999704360962},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/histological-subtypes","display_name":"histological subtypes","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9168212413787842},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7344131469726562},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.680179238319397},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5819936990737915},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5764998197555542},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46216604113578796},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.44293272495269775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4322274327278137},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.41803786158561707}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-15-c11","doi":"https://doi.org/10.1158/1535-7163.targ-15-c11","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c11","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2607591686","https://openalex.org/W2089716357","https://openalex.org/W2460081483","https://openalex.org/W2168334299","https://openalex.org/W2125020910","https://openalex.org/W7139843389","https://openalex.org/W2603780327","https://openalex.org/W2073405701","https://openalex.org/W2002373091","https://openalex.org/W2003844911"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"EGFR":[2,36,60,65,90,269,274,364,372,391,396,417,425],"inhibitors,":[3],"erlotinib":[4,228],"and":[5,79,99,151,162,176,197,207,215,283,298,309,347,437],"gefitinib,":[6],"cause":[7],"tumor":[8,135],"shrinkage":[9],"in":[10,23,30,121,142,173,240,250,416],"approximately":[11],"70%":[12],"of":[13,33,44,54,59,69,75,133,223,238,259,354,390,414,430],"non-small":[14,419],"cell":[15,420],"lung":[16,421],"cancer":[17,422],"(NSCLC)":[18],"patients":[19,34,63,88,106,118,224,239,249,267,291,362,394,423],"with":[20,35,64,89,95,180,227,268,292,324,338,371,384,395,424],"activating":[21],"mutations":[22],"EGFR,":[24],"but":[25],"may":[26,366],"also":[27,367],"be":[28,317],"efficient":[29],"a":[31,41,52,256,325],"subset":[32],"wildtype,":[37,91],"as":[38],"indicated":[39],"by":[40,147,154,160,164],"retrospective":[42],"analysis":[43,353],"the":[45,73,241,251,277,289,321,329,351,385,431],"BR.21":[46],"trial.":[47],"However,":[48],"there":[49,264],"is":[50,359],"currently":[51],"lack":[53],"biomarkers":[55,71,412],"predictive":[56,413],"for":[57,110,187,302],"outcome":[58,389,415],"inhibitor-treated":[61,392,418],"NSCLC":[62,87,393],"wildtype.":[66,397,426],"The":[67,191,221],"identification":[68,163],"such":[70],"was":[72,245,306],"aim":[74],"this":[76],"study.":[77],"Materials":[78],"methods:":[80],"Formalin-fixed":[81],"paraffin-embedded":[82,129],"tissue":[83],"blocks":[84],"from":[85,273,369],"50":[86,290],"who":[92,271],"received":[93,234],"treatment":[94,370],"erlotinib/gefitinib":[96],"were":[97,137,140,171,185,201,204,209,225,300,314],"included":[98],"stratified":[100],"according":[101],"to":[102,316,387],"progression-free-survival":[103],"(PFS).":[104],"Twelve":[105],"experienced":[107,119],"no":[108],"progression":[109,120],">6":[111],"months":[112,123],"(Good":[113],"Response":[114,125,243,253],"Group),":[115],"while":[116,232,248],"38":[117],"<6":[122],"(Poor":[124],"Group).":[126],"From":[127,276,350],"formalin-fixed":[128],"surgical":[130],"resections,":[131],"areas":[132],"high":[134],"content":[136],"isolated;":[138],"peptides":[139,184],"extracted":[141],"triethyl":[143],"ammonium":[144],"bicarbonate/acetonitrile":[145],"buffer":[146],"heat-induced":[148],"antigen":[149],"retrieval,":[150],"then":[152],"fractionated":[153],"hydrophilic-interaction":[155],"liquid":[156,165],"chromatography":[157],"(HILIC)":[158],"followed":[159],"quantification":[161],"chromatography-tandem":[166],"mass":[167,376],"spectrometry":[168],"(LC-MS/MS).":[169],"Samples":[170],"analyzed":[172],"technical":[174],"duplicates,":[175],"only":[177],"proteins":[178,287,312,336,383],"identified":[179,282,379],"minimum":[181],"2":[182],"unique":[183,294],"used":[186,301],"further":[188],"analysis.":[189,304],"Results:":[190],"patient":[192,356],"cohort":[193],"represented":[194],"20":[195],"men":[196],"30":[198,311,380],"women.":[199],"Two":[200],"non-smokers,":[202],"45":[203],"smokers/former":[205],"smokers":[206],"three":[208,233],"unknown.":[210],"42":[211],"exhibited":[212,217],"adenocarcinoma":[213],"histology":[214],"eight":[216],"bronchioalveolar":[218],"carcinoma":[219],"histology.":[220],"majority":[222],"treated":[226],"(n":[229],"=":[230],"47),":[231],"gefitinib.":[235],"Mean":[236],"PFS":[237,258,352],"Good":[242],"Group":[244,254],"455":[246],"days,":[247,261],"Poor":[252],"had":[255],"mean":[257],"66":[260],"indicating":[262],"that":[263,361],"are":[265],"indeed":[266],"wildtype":[270,365],"benefit":[272,368],"inhibitors.":[275,373],"quantitative":[278],"LC-MS/MS":[279],"analysis,":[280],"we":[281,334,378],"quantified":[284],"3152":[285],"high-confident":[286],"across":[288],"\u22652":[293],"peptides.":[295],"Softwares":[296],"R":[297],"GProX":[299],"statistical":[303],"Data":[305],"quantile":[307],"normalized":[308],"revealed":[310],"which":[313],"found":[315,335],"differentially":[318,331,381],"expressed":[319,332,382],"between":[320],"two":[322],"groups":[323],"p-value":[326],"<0.01.":[327],"Among":[328],"most":[330],"proteins,":[333],"involved":[337],"cytoskeletal":[339],"rearrangement,":[340],"intracellular":[341],"transport,":[342],"protein":[343],"translation,":[344],"transcription":[345],"regulators":[346],"kinases.":[348],"Conclusions:":[349],"our":[355],"cohort,":[357],"it":[358],"clear":[360],"exhibiting":[363],"Using":[374],"unbiased":[375],"spectrometry,":[377],"potential":[386],"predict":[388],"Citation":[398],"Format:":[399],"Kirstine":[400],"Jacobsen,":[401],"Brian":[402],"Hood,":[403],"Karen":[404],"Ege":[405],"Olsen,":[406],"Thomas":[407],"Conrads,":[408],"Henrik":[409],"Ditzel.":[410],"Protein":[411],"[abstract].":[427],"In:":[428],"Proceedings":[429],"AACR-NCI-EORTC":[432],"International":[433],"Conference:":[434],"Molecular":[435],"Targets":[436],"Cancer":[438,449],"Therapeutics;":[439],"2015":[440],"Nov":[441],"5-9;":[442],"Boston,":[443],"MA.":[444],"Philadelphia":[445],"(PA):":[446],"AACR;":[447],"Mol":[448],"Ther":[450],"2015;14(12":[451],"Suppl":[452],"2):Abstract":[453],"nr":[454],"C11.":[455]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}